Correlation of enzyme-inducing anticonvulsant use with outcome of patients with glioblastoma

Neurology. 2010 Apr 20;74(16):1330-1; author reply 1331. doi: 10.1212/WNL.0b013e3181d8a5c2.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Anticonvulsants / pharmacology*
  • Anticonvulsants / therapeutic use
  • Antineoplastic Agents / agonists
  • Antineoplastic Agents / therapeutic use
  • Brain Neoplasms / drug therapy*
  • Brain Neoplasms / mortality*
  • Brain Neoplasms / pathology
  • Clinical Trials as Topic / methods
  • Clinical Trials as Topic / standards
  • Comorbidity
  • Data Interpretation, Statistical
  • Disease Progression
  • Enzymes / drug effects
  • Enzymes / metabolism
  • Epilepsy / drug therapy
  • Epilepsy / epidemiology*
  • Epilepsy / physiopathology
  • Glioblastoma / drug therapy*
  • Glioblastoma / mortality*
  • Glioblastoma / pathology
  • Humans
  • Incidence
  • Outcome Assessment, Health Care / methods
  • Outcome Assessment, Health Care / standards
  • Severity of Illness Index
  • Survival Rate
  • Treatment Outcome

Substances

  • Anticonvulsants
  • Antineoplastic Agents
  • Enzymes